在胃肠道外科手术中使用单剂量经手术的抗生素预防
Lancet (London, England)
|August 14, 1976
概括
在胃肠道手术前给出的单剂托布拉米和林科米大大降低了手术后的伤口感染率,从34%降至5%. 这种抗生素组合证明对有氧和无氧细菌安全有效.
科学领域:
- 手术感染预防手术感染预防.
- 临床药理学 临床药理学
- 微生物学 微生物学
背景情况:
- 手术后的伤口感染在胃肠道手术中构成重大风险.
- 有氧和无氧细菌是手术部位感染中常见的病原体.
研究的目的:
- 评估单次静脉注射托布拉米辛和林科米辛在预防术后伤口感染方面的疗效.
- 评估这种抗生素治疗方案的安全性和对细菌菌群的影响.
主要方法:
- 在胃肠道手术开始时静脉注射托布拉米和林科米.
- 对术后伤口感染率的监测.
- 在伤口中评估细菌的存在 (有氧和无氧).
- 对抗生素毒性的评估和耐药菌株的发展.
主要成果:
- 观察到,术后伤口感染发病率从34%显著降低到5%.
- 治疗有效地减少了无氧和有氧细菌的发生.
- 在大多数患者的手术期间,治疗性抗生素度保持不变.
- 没有检测到任何不良的毒性影响或麻醉并发症.
结论:
- 单次手术前静脉注射一剂托布拉米和林科米在减少胃肠道手术后手术伤口感染方面非常有效.
- 抗生素治疗方案耐受性良好,不会导致耐药细菌菌株的出现.
- 这种预防策略为胃肠道外科手术中的感染控制提供了一种安全和有益的方法.
相关概念视频
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...


